Page 1 Mémoire de Diplôme dEtudes Supérieures dHépato-Gastro-Enterologie Nicolas Williet Inflamm Bowel Dis (In press) Inflamm Bowel Dis (In press) Le 15 Octobre 2011…

Riesgo de tumores en la EII Isabel Ferrer Hospital de Manises 26 de Octubre del 2013 Bibliografía revisada. ECCO Sebastian S, Hernández V, Myrelid P, Kariv R, Tsianos E,…

Alessandro Armuzzi , Daniela Pugliese IBD Unit Complesso Integrato Columbus – Università Cattolica - Roma La terapia con anti-TNF alfa nella Colite Ulcerosa Giulio, Male,…

Slide 1 Presentation title inserted here Speaker Name Details Guía Práctica Clínica Venezolana sobre Enfermedad Inflamatoria Intestinal Noviembre, 2012 MÓDULO 4. Terapia…

Slide 1 Antibiotics and Risk of New Onset Inflammatory Bowel Disease: A Meta-Analysis Ryan Ungaro 1, Charles Bernstein 2, Richard Gearry 3, Anders Hviid 4, Kaija-Leena Kolho…

Slide 1 Other Major Side Effects to Immunomodulators and/or Biologics in Our IBD Patients Edward V. Loftus, Jr., M.D. Professor of Medicine Mayo Clinic Rochester, Minnesota,…

Other Major Side Effects to Immunomodulators and/or Biologics in Our IBD Patients Other Major Side Effects to Immunomodulators and/or Biologics in Our IBD Patients Edward…

When Should We Stop Anti-TNF Therapy and How Do We Then Treat the Patient? When Should We Stop Anti-TNF Therapy and How Do We Then Treat the Patient? James Markowitz, MD…

Slide 1 GI tract infections in IBD: Detection and treatment of Clostridium difficile, CMV and enteric pathogens: Case studies David G. Binion, MD Bruce E. Sands, MD, MS Case…

Antibiotics and Risk of New Onset Inflammatory Bowel Disease: A Meta-Analysis Antibiotics and Risk of New Onset Inflammatory Bowel Disease: A Meta-Analysis Ryan Ungaro1,…